RJA
COYA icon

Raymond James & Associates’s Coya Therapeutics COYA Stock Holding History

Raymond James & Associates’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,095
Closed -$1.09M – 3986
2024
Q1 		$1.09M Buy
+110,095
New +$863K ﹤0.01% 2540

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James & Associates's COYA Position: Q2 2024 in Review

Raymond James & Associates sold out of Coya Therapeutics (COYA) in Q2 2024, closing a stake of 110,095 shares — an estimated $1.09M sold.

Raymond James & Associates first reported a position in COYA in Q1 2024 and held it in 1 quarter. The position peaked at $1.09M in Q1 2024. 19 funds tracked by Wall St. Rank hold COYA as of Q2 2024.

  • Raymond James & Associates reported no remaining Coya Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 110,095 Coya Therapeutics shares in Q2 2024, an estimated $1.09M.
  • Raymond James & Associates first reported a position in Coya Therapeutics in Q1 2024 and held it in 1 quarter.
  • Raymond James & Associates's Coya Therapeutics position peaked at $1.09M in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.